Welcome to the e-CCO Library Archive!
Ileal pouch-anal anastomosis for dysplasia or cancer complicating inflammatory bowel disease: should a total mesorectal excision always be performed? An analysis of 39 consecutive patients.
L. Maggiori*1, C. Coton1, X. Tréton2, Y. Bouhnik2, Y. Panis1
1Beaujon Hospital, Colorectal Surgery, Clichy, France, 2Beaujon Hospital, Gastroenterology, Clichy, France
Low dose naltrexone in therapy resistant IBD, a case series
M. Lie, G. Fuhler, A. de Lima, C. van der Ent, C.J. van der Woude, Erasmus Medical Center, Gastroenterology and Hepatology, Rotterdam, Netherlands
R. Dart1,2, N. Griffin3, V. Goh3, K. Taylor1,2, S. Anderson1, J. Sanderson1,2, P. Irving1,2, 1St Thomas' Hospital, Department of Gastroenterology, London, United Kingdom, 2King's College, University of London, Nutritional Sciences Division, United Kingdom, 3St Thomas' Hospital, Department of Radiology, London, United Kingdom
Looking beyond the mucosa: transmural healing after one-year anti-TNFα therapy in Crohn's disease
M. Serio*1, K. Efthymakis1, A. Pierro2, A. Milano1, F. Laterza1, G. Maselli2, A. Bonitatibus1, R. De Prophetis1, G. Sallustio2, M. Neri1
1Università "G. D'Annunzio", Medicine and Aging Sciences and CESI, Chieti, Italy, 2Fondazione di Ricerca e Cura "Giovanni Paolo II", Università Cattolica del Sacro Cuore, Radiology Department, Campobasso, Italy
Low dose azathioprine and allopurinol in azathioprine intolerant patients: is it tolerated and is it effective in IBD?
H. Johnson, S. Weaver, S. McLaughlin, Royal Bournemouth Hospital, Gastroenterology, Bournemouth, United Kingdom
M. Widlak1, R. Matharu1, A. Elzubeir1, J. Slater1, L. Wood1, S. De Silva1, 1Russells Hall Hospital, Gastroenterology, Dudley, United Kingdom
Rapid Changes in Laboratory Parameters and Early Response to Adalimumab: Pooled Analysis from ULTRA 1 and ULTRA 2
S. Hanauer*1, W.J. Sandborn2, J.-F. Colombel3, W. Reinisch4, 5, S. Vermeire6, J. Petersson7, B. Pappalardo7, A.M. Robinson7, A. Lazar8, Q. Zhou7, R.B. Thakkar7
1Northwestern University Feinberg School of Medicine, Digestive Health Centre, Chicago, United States, 2University of California San Diego, Division of Gastroenterology , La Jolla, United States, 3Icahn School of Medicine at Mount Sinai, Gastroenterology, New York City, United States, 4McMaster University, Gastroenterology, Hamilton, Canada, 5Medical University of Vienna, Dept. for Gastroenterology and Hepatology, Vienna, Austria, 6University Hospital Leuven, Gastroenterology, Leuven, Belgium, 7AbbVie Inc., Global Pharmaceutical Research & Development, North Chicago, United States, 8AbbVie Deutschland GmbH & Co, KG, GPRD, Ludwigshafen, Germany
Low dose azathioprine and allopurinol co-therapy: is it safe to use without metabolite monitoring?
B. Eross, H. Johnson, S. Weaver, S. McLaughlin, Royal Bournemouth Hospital, Gastroenterology, Bournemouth, United Kingdom
A. Rispo1, A. Testa1, M. Rea1, G.D. De Palma2, M. Diaferia1, D. Musto1, F. Sasso1, M. Tramontano1, N. Caporaso1, F. Castiglione1, 1University Federico II Of Naples, Gastroenterology, Naples, Italy, 2University Federico II Of Naples, Surgery and Advanced Technologies, Naples, Italy
Thiopurine metabolite testing to guide management in inflammatory bowel disease (IBD) yields clinical benefit at 12 months: A retrospective observational study.
S.-Y.J. Ooi1, M. Gounder2, R. Grafton1, P. Leach3, A. Sechi2, W. Ng2, S. Connor2, P. Bampton3, J.M. Andrews*1
1Royal Adelaide Hospital, Gastroenterology and Hepatology, Adelaide, Australia, 2Liverpool Hospital, Gastroenterology & Hepatology, Liverpool, Australia, 3Flinders Medical Centre, Inflammatory Bowel Disease Service, Bedford Park, Australia
Long term results of infliximab treatment of fistulas in patients with Crohn's disease in Arctic Norway
R. Heitmann, R. Goll, J.R. Florholmen, University of Tromsø, The Arctic University of Norway, Department of Clinical Medicine, Tromsø, Norway
C. Cassieri1, A. De Carolis1, R. Pica1, E.V. Avallone1, M. Zippi1, C. Corrado1, E.S. Corazziari1, P. Vernia1, P. Paoluzi1, 1Sapienza University, Internal Medicine and Medical Specialties, “Gastroenterology Unit”, Rome, Italy
Transitional care in Inflammatory Bowel Disease - a single center experience
Y. Ron*1, A. Yerushalmy-Feler2, A. Nachum3, I. Dotan1, S. Cohen2
1Tel Aviv Sourasky Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, IBD Center, Department of Gastroenterology and Liver Diseases, Tel Aviv, Israel, 2"Dana-Dwek" Children's Hospital, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, The Pediatric Gastroenterology unit, Tel Aviv, Israel, 3Tel Aviv Sourasky Medical Center , Health and Medical Psychological service, Tel Aviv, Israel
Long term outcomes from leucocytapheresis in ulcerative colitis: A retrospective case series from a large UK centre
P. Harrow, H. Kwok, G. Parkes, P. Premchand, Queen's Hospital, Gastroenterology, Romford, United Kingdom
R. Scaramuzzo1, E. Iaculli2, C. Fiorani3, L. Biancone1, T. Giorgia3, D.C. Sara3, A. Gaspari3, G. Sica3, 1Tor Vergata, Italy, 2Guy's and St Thomas' Hospital, Surgery, London, United Kingdom, 3Tor Vergata Roma, Italy